Sponsored by:
This activity is based on footage from a 2022 event with Adjunct Clinical Associate Professor Natasha Michael, where she focused on breakthrough cancer pain as a separate entity from cancer pain.
Learning outcomes
By the end of this course, participants should be able to:
- Describe the heterogeneous nature of breakthrough cancer pain intensity and its clinical characteristics
- Describe the differences between the pharmacokinetic profiles of rapid-onset and short-acting opioids
- Assess and choose an appropriate treatment based on an individual's pain profile
This activity is endorsed by ACN according to our Continuing Professional Development (CPD) Endorsed Course Standards. It has been allocated 1 CPD hour according to the Nursing and Midwifery Board of Australia - Continuing Professional Development Standard.
Other healthcare professionals can still enrol and complete this course. You will receive a certificate upon completion.
START LEARNING
If you do not already have an account with Arterial Education, you will be required to create one. This verifies that you are a healthcare professional and allows you to log your learning activities.
